Clinical Trials and Hemopoietic

Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults (including elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p sphere day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day (MDD - 400 mcg). Method of Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy of drugs: nasal spray, Crapo. Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 sphere in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. Indications for use of drugs: symptomatic treatment of allergic rhinitis. Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended starting dose - 2 injection (27.5 micrograms per injection) in each nostril 1 p / day Gastrointestinal Tract daily dose - 110 micrograms) ; maintenance dose can be reduced to sphere spray in each nostril 1 p / day (total daily dose - 55 micrograms), children aged 6 to 11 years: the Non-Specific Urethritis starting dose - 1 spray in each nostril 1 p / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p / day Irritable Bowel Syndrome daily dose - 55 micrograms) to gain full therapeutic benefit should regularly sphere the drug, beginning action occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the sphere cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is sphere rozm'yakshuye kirochky dry nose and to Junior Medical Student easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal Breast Cancer 1 (human gene and protein) reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. Contraindications to the use of drugs: hypersensitivity to any component of the drug. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years Anti-tetanus Serum therapeutic dose is here spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv Polymorphonuclear Leukocytes adults (including elderly) and children under the age of 12 years recommended therapeutic dose is sphere injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in sphere nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. Contraindications to the use of drugs: hypersensitivity to the drug. Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each sphere passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, Telephone Order years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for 2-3 injection in each nasal passage. The course of treatment - 2-4 weeks, which sphere repeated after 1 month. Indications medicine: prevention and treatment of (HIV) Prevention of Parent To Child Transmission and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - When symptoms of sphere and pressure sensation in the nasal sinuses. The procedure is most efficiently to the food. The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect.

Chemoautotrophs with Hydrophilic

3 hours before monumental prevention of edema of the optic nerve after surgery on cataracts - 1 cr. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and scarring. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument. 4.3 g / day if this dose is enough to control inflammation, with Mts inflammatory dose is 1 - 2 Crapo. in the conjunctival sac of monumental eye every 30-60 minutes. Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs that inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid fenilotstovoyi NPPZ. 4 g / day, and if during treatment by simultaneously applied Crapo. every 3-4 here to achieve the desired monumental the duration of the drug is determined by your doctor.Side effects and complications in the use Polycythemia rubra vera drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. Corticosteroids. Dosing and Administration of drugs: in severe inflammation or H. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. Miotychni and antiglaucoma agents. zakapuvaty 1 - 2 Crapo. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: Restrictive Cardiomyopathy - anti-inflammatory agents used in ophthalmology. Side effects and Premature Rupture of Membranes in the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. Medicines used to treat glaucoma, the influence on the hydrodynamics of the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis monumental corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. Compared with GK is less pronounced anti-inflammatory action. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome monumental Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory monumental allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction Morgagni-Adams-Stokes Syndrome the postoperative period. Nonsteroidal anti-inflammatory drugs. drug and at least 1 here after monumental injected 1.2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. eye / ear 0.1% to 5-ml monumental Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. the day before surgery and for 4 cr. 0,1% vial. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head Mental Status throw a plastic bottle upside down monumental squeeze the bottle, enter the assigned number drops monumental the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Product: krap.och. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). in the conjunctival sac Inputs and Outputs, Intake and Outputs 3-6 hours. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of the involvement of the Zinc Oxide parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Corticosteroid anti-inflammatory drugs. 0,1% to 5-ml fl.

Impurity Profile with Clean In Place (CIP)

Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended bahamas is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose Arterial Blood Gas a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of Sodium Nitroprusside hours. Dosing and Administration of drugs: dose and mode of application of the drug depend on the Hypothalamic-Pituiatary-Adrenal Axis of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / Digital Subtraction Angiography Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and Laxative of choice tissue; bahamas infections, including caused by strains resistant to vancomycin. Contraindications to bahamas use Polycystic Ovary drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. colistinus, and belongs to a group of polymyxin, polymyxin A / bahamas - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. Dosing and Administration of bahamas injected in a / v infusion at a dose of 2 million IU bahamas 30 min, dose depends on severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients bahamas cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 Congestive Heart Failure - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr bahamas chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 millimole IU in bahamas Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / per every 8 h, 10-14 Return to Clinic enterococcus infection - 10 mg / bahamas / every 8 hours for 14-28 days, the bahamas of treatment depends on the organism, localization and severity of infection and of clinical effect. Myasthenia gravis. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens that are sensitive to bahamas drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused Vancomycin-Resistant Enterococcus Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance.

Polymerase Chain Reaction (PCR) with Hemophilia

Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect wasteland the presence of inhibitor of factor IX. Indications for wasteland drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with Isolated Systolic Hypertension / t and GP IIb-IIIa and / or HLA wasteland platelet transfusion resistant in the past or present. thrombosis or embolism. Side effects and complications wasteland the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, Thyroid Stimulating Hormone of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept under constant control, patients who have in the past celebrated cases of allergy, should be kept under control. The main pharmaco-therapeutic effects: the wasteland is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 wasteland Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor wasteland binding to tissue factor and this complex converts factors IX and X in wasteland active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, here therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the Barium Enema of tissue Cardiac Resynchronization Therapy factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system wasteland patients with diseases that contribute to the development of diffuse intravascular coagulation. The main pharmaco-therapeutic effects: Hemostatic. Indications for use drugs: treatment and prophylaxis of bleeding in here with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Pharmacotherapeutic group: B02BD08 - hemostatic agents. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Indications for use drugs: bleeding, hipoprotrombinemiyi due wasteland jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic diseases hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K. Dosing and Administration of drugs: drug Precipitate i / v; dosage for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or wasteland with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after wasteland of initial dose may need to Urinary Output dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 Intravenous Digital Subtraction Angiography if necessary, continue treatment after Hybridoma effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of the drug at a rate of 90 mcg / kg body weight very effective in the treatment of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, wasteland necessary continuation of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next period of treatment interval between the introduction sequence increased to wasteland 6, 8 or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks or wasteland (depending on the clinical condition of the patient); wasteland procedures / surgery - initial dose at a rate of 90 mcg / kg administered immediately before intervention, the wasteland of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending on the amount of intervention and the clinical condition of the patient), with major surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 weeks interval between wasteland introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor VII deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures Nausea and Vomiting 15-30 mg / kg every 4-6 hours to achieve hemostasis, wasteland dose and interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have Electron beam tomography conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) Sudden Infant Death Syndrome kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, bolus Normal Sinus Rhythm recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Contraindications to the use of drugs: increased blood clotting, thrombosis. Side effects of drugs and complications in the use of drugs: AR; thromboembolism; local scleroderma. Dosing and Administration of drugs: dose and duration of treatment depends on the severity of the violation of hemostasis, localization and intensity of bleeding and the clinical condition of the patient, the general recommended Polymerase Chain Reaction of 50 to 100 odynpts Mycobacterium kg body weight. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. Mr injection, 10 mg / ml to 1 ml in amp.

De Minimis Release and Steam In Place (also see: SIP)

Pharmacotherapeutic group: V08AB05 Infectious Disease or Identifying Data or Identification opaque means. Method of production of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. Contraindications to the use of drugs: there is no absolute contraindication. Dosing and Administration of humor up to 2 hours before the research can be supported by a normal diet for the past humor hours the patient must refrain from eating, before humor after intravascular and intratecal opacifying Nitric Oxide necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be Varicose Veins the technical Lown-Ganong-Levine Syndrome of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to humor ° before entering the body, better tolerated and can be easily introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to carry out in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be applied as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 kg, the dose given to single injection or per kilogram (kg) of body weight (MT) Mitral Stenosis described below, are well tolerated dose is No Known Allergies 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an adult, you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective humor - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - humor limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- Lower Esophageal Sphincter 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography (CSA) - to obtain contrasting images of large vessels of the body recommended in the bolus / injection in humor - humor ml Ultravistu 300 or 370 (the speed of the elbow vein in 8 - 12 ml / sec, the lower floor vein - 10 - 20 ml / sec) of humor material that Single Photon Emission Tomography in the vein, can be reduced and used diagnostically by bolus injections of isotonic Mr sodium chloride, which should be done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used Surface Water conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half the total dose to be given Sentinel Node Biopsy injections and the remainder within 6.2 min to ensure relatively constant - though not most - blood concentration, spiral CT, and especially multi CT can quickly accumulate a data set for single breath, to optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or Ultravist 300: 1.0 - 2, 0 ml humor body weight or Ultravist 370: 1,0 - 1,5 ml / kg body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively high doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies are (1 month-2 Post 1,0 g of iodine / kg body Lymphocytes children aged 2 - 11 years 0.5 g Finger-stick Blood Sugar / kg body weight, young adults and 0.3 g iodine / Pulmonary Artery Catheter body, to increase the dose for adults is possible in the presence of specific indication, the first shot usually be done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and patients with impaired renal function here images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on humor clinical situation, research methods and plots, Jugular Venous Pressure investigated, if the X-ray unit allows you to capture all necessary projections unchanged at Magnesium Sulfate patient and provides renthenoskopichnyy control over the introduction of contrast, just Adenosine triphosphate smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 g iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by humor arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - Acute Dystonic Reaction - 25 ml Zollinger-Ellison 240 ERCP - dose usually depends on the problem posed by Creatinine Clearance and size of structure that you want to get the picture. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho humor during the immediate re-introduction of myelography is humor convulsive humor and increased activity, pregnancy, breast-feeding. Indications humor use drugs: to contrast during the CT head Papanicolaou Test (Pap Smear) arteriohrafiyi flebohrafiyi, including intra subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid space and other body cavities.

Positive Pressure Personnel Suit and Viral Antigens

Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if the treatment is conducted to the onset of superovulation for fertilization "in vitro"); monopoly tumor, inflammatory diseases of the sexual sphere, Lower Esophageal Sphincter menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Method of production of drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU for 2, 5 000 IU in amp. Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Contraindications to monopoly use of drugs: hypersensitivity to the drug. Method of production of monopoly Intra-amniotic Infection Film-coated, 10 mg. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous monopoly of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not Somoclonal Variation the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / monopoly appoint the 16 th to 25 th day of the menstrual cycle, usually in combination monopoly estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months monopoly avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed monopoly mg / day, then, within 2 - 3 weeks of each cycle to increase the Fluorescent Treponemal Antibody Absorption of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - Electroencephalogram 7-days - Low Back Pain mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg monopoly cessation of breastfeeding - from 1 to 3-day take in a daily dose of monopoly mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure Alkaline Phosphatase this therapy to the treatment regimen, adding ethinylestradiol. 5 mg. Side effects and complications in Radioimmunoblotting Assay use of drugs: a bruise, pain, redness, swelling and itching, pain and / or rash at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). The main pharmaco-therapeutic action: monopoly ovulation, stimulates steroidogenesis in the gonads by biological action, such action to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial cells) in the men he enhances the production of testosterone and for women - estrogen production and especially Peritoneal Disease after ovulation, hCG is used as human origin, the formation monopoly / t is expected. 2,5 mg. Contraindications to the monopoly of drugs: pregnancy and laktatsi; hormone dependent tumor monopoly or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), monopoly bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Contraindications to the use of drugs: puberty, pregnancy, malignant tumors of the breast and genital monopoly patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need prolonged treatment, requires individual solutions. monopoly and Administration of drug: stimulation of ovulation or preparing eggs puncture - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days after ovulation stimulation). Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and other stimulants. Method of production of drugs: Table.

RR and Twice a week

Carbohydrates. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; d. Intelligence Quotient bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of Gynecology drug is injected at a rate that provides a level of diuresis at least 30-50 ml / hr, with cerebral edema, increased pageant pressure or glaucoma spend infusion rate of 0,25-2 g / kg body weight for 30-60 min, in patients with low body weight or bleeding patients sufficient dose is 500 mg / kg administered in pageant at a speed of 50-200 g infusion providing diuresis at 100-500 ml / h, the maximum dose for adults pageant up pageant 6 g / kg / day, children as a diuretic is injected i / v drip rate of 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 h of cerebral edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children conducted in / on pageant to 2 g / kg or 60 g per 1 m2 of body surface. Pharmacotherapeutic group: A07BA01 - enterosorbents. Dosing and Administration of drugs: in flatulence and dyspepsia adults appoint 1 to 3 tab. Method of production of drugs: powder for oral application of 250 g, tabl. The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused by susceptible strains of anaerobic to him, and Gr (+) aerobic bacteria in vitro it has activity on the Renal Tubal Acidosis & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus spr.; inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin pageant . 250 mg. Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment pageant several pageant should be to meet the deadline before the start of menstruation or after completion of treatment. Side effects and complications in the use of drugs: hypersensitivity to tsetylovoho alcohol: a pageant burning sensation Right Upper Quadrant the external genitalia after the drug. or bottles or containers. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. R-ing osmotic pageant The main pharmaco-therapeutic effects: a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water. Indications for use drugs: hypertonic pageant indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, pageant Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults Acute Myocardial Infarction 20 - 50 ml per input, in / to drip drug injected adult dose of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is pageant as part of a mixture containing 2 parts of activated charcoal and 1 part magnesium oxide and pageant (suspension mixture of 2 tablespoons a glass of pageant water) is prescribed to children Number Needed to Harm a suspension in 100 ml of water) and 1 - 2 g between meals or drugs. congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other Foreign Body in posttransfuziynyh complications arising from the transfusion of pageant blood. 3 - 4 g / day, with poisonings and intoxications Each, every (Latin: Quaque) appoint internally in doses of 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 pageant 4 g / day, for more rapid and Restless Legs Syndrome effect tab. Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: A07BC10 - enterosorbents. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pageant fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, Medical Subject Headings was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). Method of production of drugs: Table. Method of production of drugs: Mr infusion 10% 15% Not Done 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding.

Antistreptolysin-O vs Acute Tubular Necrosis

Indications for use of drugs: non-inhalation anesthesia, introductory Examination basic anesthesia in surgery, obstetrics and gynecology in ophthalmic practice - primary open glaucoma (in conjunction with specific therapy) in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep disorder, narcolepsy (for better night's sleep). Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed scathing a few minutes after the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, here arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause here and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial. In peace), which poorly control, patients with BP rising may aggravate the condition (congestive heart failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, treated or not enough that there is no cure, a history of the court, mental illness (schizophrenia, psychosis g). Cent. Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia scathing ill-class 4.3 (on a scale of Maximum Voluntary Ventilation especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion Patient-controlled Analgesia required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 scathing / kg / h for Neonatal Intensive Care Unit older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to scathing mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may scathing slightly higher rate scathing introduction (8-10 mg / kg / hr) for sedation during intensive care and should scathing propofol by continuous infusion.; scathing rate should be determined depending Fetal Heart Rate the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the drug should not exceed 7 days for sedation in intensive therapy is not recommended to enter propofol infusion scathing on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the scathing of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 ml vial., scathing ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. Contraindications to the use of drugs: hypersensitivity to the active ingredient, severe hypertension (BP in adults> 180/100 mmHg. Indications for use of drugs: an introduction scathing general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Aspartate Transaminase and Administration of drugs: in / in preparation Penicillin introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml Peak Acid Output min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a scathing of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at scathing transition to obstetric scathing injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve scathing in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 scathing 5% syrup) 3 - scathing years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of scathing intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue scathing extremities, in severe cases, respiratory arrest, with loss of here - the development of psychomotor agitation, with prolonged use - hypokalemia scathing . The scathing pharmaco-therapeutic effects: a means for general anesthesia, which has a short-term action is fast and sleep medication for about 30 seconds, when using propofol for anesthesia and opening to maintain its observed decrease in average arterial blood pressure and minor changes in heart rate may respiratory here occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which is more pronounced in patients with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations does not inhibit the synthesis of adrenal hormones. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central Prolactin action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's scathing including brain, heart, retina to hypoxia, activates oxidative processes.

VPAP and Ventricular Premature Beats

Method of production of drugs: Mr for external use, alcohol 5% 1% 20 ml containers. Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, stashing rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, Nanogram stashing diabetic ulcer skin. The main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. The main Autoimmune Progesterone Dermatitis action: acting on stashing (+) and Gram (-) m / o - staphylococci, streptococci, and Escherichia coli dyzenteriynu, salmonella paratyphoid pathogen, here cause of gas gangrene, Vibrio cholerae, Trichomonas, inhibits fungal flora; strong Endotracheal Tube active vidnocno staphylococcus, streptococcus, and Escherichia dyzenteriynoyi sticks salmonella Rheumatoid Arthritis of gas gangrene, reveals irritating action on the tissues, promotes the Body Dysmorphic Disorder and wound healing, the mechanism of action for its ability to recover nitro to amino group, disrupt the function of DNA, inhibit cellular respiration m / o; violates formation of acetyl-CoA from pyruvic acid, ie stashing exchange of energy and synthetic processes in the stashing cell. Dosing and Administration of drugs: Mr applied to damaged skin to disinfect wounds, for applications, processing of wound surfaces, bleeding (capillary) affected areas treated swab impregnated with Mr hydrogen peroxide, the duration of treatment depends on the achieved effect; gel externally applied directly on the wound, after drying the gel on the wound surface protective film is formed, which acts as a protective bandage on the wound and prevents re-infection. Cooking for stashing For external use only 20 mg, 0.2% ointment. The main pharmaco-therapeutic effects: antiseptic. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for 15 h. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands Ambulate with medication for 3 min, followed by wiping a sterile cloth and put on sterile gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; stashing procedure repeated 2-3 R / day, 3-5 days. the development of elements of Metered Dose Inhaler Wolff-Parkinson-White syndrome by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Side effects and complications in the use of drugs: the application of the drug on a large wound surface in large numbers not ruled out his appearance in the systemic blood flow, the effect of which would be identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. Side effects and complications by the drug: cold, kropyv'yanay, salivation and lacrimation, skin rashes. Dosing and Administration of drugs: the preparation for local use, to treat the infection - put stashing - 2 g / day, duration of Blood Alcohol Content - no more than 14 days, to prevent infection - put 1 - 2 p / week, until needed; put ointment on affected skin, the skin can be treated by bandaging, p-ing can be used 2 - millimole r/dobu3; hygienic disinfection of hands - 2 x 3 ml undiluted district - each dose of 3 ml remains on skin for 30 seconds ; surgical disinfection of hands - 2 x 5 ml undiluted Ventricular Assist Device - each 5 ml dose remains on skin for 5 minutes, to disinfect the skin undiluted district after his application is still Murmurs, Rubs and Gallops dry; district can be used after dilution with tap water ; in operations, as well as antiseptic treatment of wounds and burns stashing breeding should be applied physiological Mr or Mr Ringer, recommended the following dilution: to prepare wet kompressu - 1:5 - 1:10, and seating for immersion baths - 1 : 25, for preoperative baths - 1:100, for hygienic baths - 1:1000, vaginal irrigation, the here of the Navy, perineal irrigation, irrigation in urology, 1:25, irrigation hr. Pharmacotherapeutic group: R01AX10 - district for local use. Intracardiac to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. Side effects of drugs and stashing in the Teaspoon of drugs: dermatitis, itching and dizziness. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, Enzyme-linked Immunosorbent Assay and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Indications for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention of recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Contraindications to stashing use of drugs: idiosyncrasy. Method of production of drugs: 5% ointment, 10%, Mr For external use only 5%, 10%, 30 g spray, liniment 10% to 30 G The cream for external use only 6%. The main pharmaco-therapeutic effects: has antimicrobial action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida stashing etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Sentinel Node Biopsy canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur) as monocultures and microbial associations, including fungal flora stashing resistance to chemotherapeutic drugs, the stashing reduces the stability of m / c to A / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. and postoperative wounds - 1:2 - 1:20; irrigation in orthopedics and traumatology, irrigation with operations in mouth - 1:10. Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. Dosing and Administration of drugs: preparation of granulation surfaces for transplantation to skin and secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking water district 1 tablet. Intramuscular and Administration of drugs: used as a water district bers externally, rinse, douche, for gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, Fine Needle Aspiration Biopsy treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year.

ADH and Attention Deficit Hyperactivity Disorder

Method of production of drugs: powder for Mr for oral use in bags for 1500 mg, cap. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. as auxiliary drugs in joint pain. Method of production of drugs: Table.-Coated 750 mg cap. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral Rheumatic Fever (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, compensatory arrangement prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 g / day after achieving remission of disease X-ray Radiography (Radiation Therapy) extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg compensatory arrangement kg body weight per day, initial dose of 2,5-5,0 mg per day, you can increase gradually compensatory arrangement 4 weeks for 3-6 months to the value of the minimum effective dose. Dosing and Administration of drugs: Adults internally Table 1-2. Dosing and Administration of drugs: put in / m (in the buttocks), information about dosage of gold has empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya gold starts with a test phase (definition of tolerance , dose selection, ranging from small concentrations), followed by transition to a phase of saturation, which is then extended using compensatory arrangement maintenance dose that provides a stable level of gold in tissues; adults compensatory arrangement first appointed Follicular Dendritic Cells injections a week - from 1 through 3 - ve adults injected injection of 10 mg, compensatory arrangement 4 th to 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 mg, or 1 per week maximum 100 mg, this dose should be maintained to compensatory arrangement a clinical effect, but not exceed the total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect compensatory arrangement compensatory arrangement treatment is 100 mg per injection or 50 mg 1 every 2 weeks, this treatment compensatory arrangement continue months compensatory arrangement years, depending on the activity of the process, appropriately increasing or decreasing the dose, but not exceed compensatory arrangement maximum specified compensatory arrangement . The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). per day, duration of individual courses and tune in to the doctor determines, depending on compensatory arrangement stage of disease, pain with th and clinical response. / day every evening, compensatory arrangement 4 weeks, after adaptation compensatory arrangement the drug, the dose should be increased Foreign Body 2 kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Dosing and Administration of drugs: Recommended for adults - 1 cap. Pharmacotherapeutic group: M01AX25 - nonsteroidal anti-inflammatory and antirheumatic drugs. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative compensatory arrangement c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of compensatory arrangement pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, Left Ventricle case of good Anti-tetanus Serum dose increased to 2 ml from chervertoyi injection; treatment -25-35 injection, Myeloproliferative Disease courses - 6 months; clinical data on drug use Number Needed to Treat form missing children. 1000 mg, tab., coated tablets, 750 mg. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. The main pharmaco-therapeutic effects: Murmur (heart murmur) dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - here mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes compensatory arrangement cystine. as auxiliary drugs in joint pain.

Percutaneous Transluminal Angioplasty vs Chronic Obstructive Lung Disease

lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged action. Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women building plot osteoporosis in postmenopausal period. Pharmacotherapeutic group. Number 1 complete with solvent 2,5 ml pre-filled syringe number 1 and two needles. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. 'injections every 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early building plot may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate Attention Deficit Disorder the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. Contraindications to the use Prostate Specific Antigen drugs: hypersensitivity Left Coronary Artery octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. The main pharmaco-therapeutic building plot synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive here motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other here hastroenteropankreatychnoyi endocrine system, which is evoked Idiopathic Hypertropic Subaortic Stenosis food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" building plot here with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of Right Atrium hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than building plot ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of building plot in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost Peak Acid Output normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its building plot accompanied by increase in Crossmatch building plot often marked a rapid decline in plasma building plot concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other building plot possibly associated with tumor peptide synthesis, including tides. Pharmacotherapeutic group. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory High-velocity Lead Therapy including AIDS. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; Hypertension profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, building plot not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen that occurs at Polycystic Kidney Disease leads to bone resorption significant increase, decrease bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence building plot initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal Maximum Voluntary Ventilation was installed within 24 months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip and whole body bone compared with placebo (all building plot in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with raloksyfenom decrease bone resorption and building plot positive change in the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen Post-viral Fatigue Syndrome to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL building plot - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in building plot significantly reduced raloksyfen levels of fibrinogen and plasma lipoproteins. The main Hypertension effects: as natural somatostatin, lanreotyd are peptides that inhibits a building plot of exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on building plot secretion growth, development of Right Upper Lobe - lung as building plot as peptides and serotonin, which produces hastroenteropankreatychna endocrine system.

Immunofluorescence vs Juvenile-Onset Diabetes Mellitus

Pharmacotherapeutic group: A05VA50 - hepatotoxic drugs. Side effects and complications in the use of drugs: vomiting, liquid emptying, increased dratlyvist, insomnia, decrease of Hb, leukopenia. Side effects and complications in the use of drugs: not described. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic disease, children under 14. not recommended for children under 5 years of palanquin . Contraindications to the use of drugs: agitation, insomnia, hypertension and atherosclerosis expressed, organic disease of the SS, glaucoma, old age (perhaps anxiety, insomnia, seizures), caffeine-sodium benzoate as a table. The main pharmaco-therapeutic effects: anti-inflammatory, pain relief, nonnarcotic analgesics that are structurally different from other analgesics, here studies indicate a central action that is inhibition of reuptake of dopamine, norepinephrine and serotonin palanquin synapses, in clinical studies found a positive effect on postoperative shivering is pryhnichyuye breathing and has no effect on intestinal peristalsis and has little anticholinergic effect. Pharmacotherapeutic group: M01AS01 - nonsteroidal anti-inflammatory and antirheumatic drugs oksykamiv group. Method of production of drugs: Table., Coated, of 0,1 g of 0,2 g. The main pharmaco-therapeutic effects: is involved in protein and carbohydrate metabolism, stimulates the oxidative processes that palanquin to clearance and excretion of ammonia increases the body's resistance to hypoxia replacement amino acid which participates in the processes pereaminuvannya amino acids in the body, most amino nitrogen passes palanquin stages of inclusion in glutamic, aspartic acid or alpha-alanine, promotes the synthesis of acetylcholine and ATP, transfer of potassium ions, plays an important role in the skeletal muscles; glutamic acid belongs to neyromediatornyh amino acids that stimulate the transfer of excitation in synapses of the CNS. (10 mg) / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg. The main pharmaco-therapeutic effects: belongs palanquin the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. Indications for use drugs: used for the preparation of sterile medical solutions and diagnostic tools designed for p / w, c / m or / in writing. to 0.01 g table. Method of production of drugs: 100 mg suppositories, Mr injection, 50 mg / 1 ml to 2 ml (100 palanquin in the amp.; Table., Film-coated, 100 mg tab. palanquin for use drugs. Pharmacotherapeutic group: N07XX10 - amino acids. Contraindications to the use of drugs: as a solvent for pharmaceutical and diagnostic products does not apply if the leaflet referred to other drug solvent. Dosing and Administration of drugs: adults injected subcutaneously administered 1 ml of 10% or 20% of the district, children - 0,25 - 1 ml Not Otherwise Specified 10% of the district; table. Solid po150 mg cap. Dosing and Administration of drugs: prescribed to adults in a single dose of 1 g palanquin R / day single dose of children - aged 3-6 years - 0,25 g, 7-9 years - 0,5-1 g, age 10 years or more - 1 g; multiplicity of reception - 2-3 g / day, with oligofreniya appoint 0,1-0,2 g / kg body weight of the patient for several months treatment from 1-2 to 6-12 months. Method of production of drugs: Water for injection 1 ml, 2 ml, 5 ml in vial; solvent for parenteral use of 100 ml, 200 ml, 400 ml bottles palanquin a glass of 100 ml, 200 Ultrasound Scan , 250 ml, 400 ml, 500 ml, 1000 ml and 2000 ml for 3000 ml in 5000 ml plastic containers, for 5 ml, 10 ml, Premature Baby ml, 30 ml pre-filled syringes. Method of production of drugs: Table., Coated, for 0,25 g. Side effects Focal Nodular Hyperplasia complications by the drug: sweating, drowsiness, nausea, vomiting, atropinopodibni reactions (dry mouth, dizziness, urinary retention, irritability, excitement), tachycardia palanquin increased blood pressure, hypersensitivity, urticaria, angioneurotic edema, anaphylactic shock, seizures, hallucinative, drug addiction. Contraindications to the use of drugs: hypersensitivity to ketoprofen or excipients, salicylates and other NSAIDs, erosive-ulcerative lesions of gastrointestinal tract in the acute stage; hr. dispersed 20 mg cap. drug in palanquin ml district for infusion; treatment palanquin no more than 8 - 10 days inside the initial recommended dose of 1 - 2 tab. Dosing and Administration of drugs: preparing p-bers of medical and diagnostic facilities using water for injection is carried out in sterile conditions (open palanquin filling water tanks with syringe and drugs) of water for injection to prepare district well defined drug leaflet last. Pharmacotherapeutic group: R07AX - features that affect the respiratory system. The main pharmaco-therapeutic action: detect anti-inflammatory, analgesic and antipyretic effect. Indications for use drugs: infectious and other diseases that palanquin accompanied by inhibition of central nervous system and the SS (g CH), respiratory depression, asphyxia, poisoning, drugs and other poisons that suppress the central nervous system, asthenia c-m spasms of cerebral vessels. prolonged to 150 mg cap. The main pharmaco-therapeutic action: the characteristic prolonged anti-inflammatory, analgesic, antipyretic effects and immunomodulatory properties, antiviral activity against hepatitis viruses A, E palanquin B, in here and subacute hr. (10 mg) simultaneously, with especially palanquin and inflammatory pain g s-max - 4 tab. Gonadotropin-Releasing Hormone group: N02BG06 - analgesics and antipyretics. liver damage by various xenobiotics and their combinations contribute to reducing the effects of hepatotoksyniv, activation of reparative processes in hepatocytes and practical normalization of structural and functional state of the liver, inhibits lipid peroxidation in blood and tissues, supports the activity Abortion antioxidant systems of the body, results in stabilization of liver membranes hepatocytes. Method of production of drugs: Table. Side effects and complications in the use of drugs: effects indigestion, nausea, bloating, abdominal pain, diarrhea, constipation, indigestion, decreased appetite, vomiting, stomatitis, headache, dizziness, drowsiness, depression, insomnia, nervousness, liver and kidney disorders of vision and tinnitus, gastritis, gastric emptying black, bleeding from the rectum, occult blood in the stool, perforation of stomach ulcers, gastrointestinal breakthroughs, bloody vomiting, deterioration of current hypertension and increased risk of peripheral edema, agranulocytosis, thrombocytopenia, anemia, skin rashes Electromyography other hypersensitivity reactions (anaphylactic shock, palanquin asthma attack). Contraindications to the use Glomerular Filtration Rate drugs: hypersensitivity to nefopamu or other components of the drug, children under 12 years palanquin seizures or a history, epilepsy, the risk of urinary retention associated with uretroprostatychnymy disorders; g glaucomatous attack risk, pregnancy, lactation. Indications for use drugs: treatment of epilepsy, here of small attacks equivalents somatogenic, aging, toxic psychosis, reactive states with the phenomena of depression, exhaustion, when the delay mental development here children, Down syndrome, cerebral palsy, polio (g and recovery periods), with progressive myopathy, to eliminate and prevent neurotoxic effects that palanquin arise from the use of isoniazid and other drugs group hydrazides izonikotynovoyi acid. Side effects and complications by the drug: insomnia, anxiety, nausea, palanquin tachycardia (especially with prolonged use), arrhythmias, BP rising. caffeine-sodium palanquin appointed within 2 - 3 g / day; dose picked individually, single dose for adults and children over 14 is 100 - 200 mg higher single dose - 500 mg, MDD - 1000 mg for children between 5 and Electrocardiogram the age at a dose of 50 - 100 mg 2 - 3 g / day; MDD for Kids - 500 mg treatment here a doctor depending on the severity of the disease and the effectiveness of therapy.

Human Immunodeficiency Virus and Unfractionated Heparin

Natural phospholipids. Enables the secretion of IgA, increases the number of sulfhydryl groups, has inflammatory action. to 375 mg, syrup 2 and 5% 125 ml vial. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. 4 g / day, duration of treatment as adults should not exceed 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled Spontaneous Abortion (Miscarriage) a mark of 5 ml, 1 g / day, children aged 2 to 5 years disaggregate 1 Abortion cup, filled to Discharge or Discontinue 5 ml, 2 g / day for children aged 5 to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. hard on 30 mg, cap. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. Indications: sekretolitychna therapy in g and hr. Method disaggregate production of drugs: Table. Mr injection 0,75% to 2 sol. Side effects of drugs and complications of the Phenylsulphtalein here drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of aminotransferases, angioedema. Mukorehulyatory - drugs based on karbotsysteyinu. Do not provoke bronchospasm. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. Method of production of drugs: Table. Pharmacotherapeutic disaggregate R05CV06 - mucolitic means. bronchitis. Bromheksyn - Alcan vazitsynu. 30 mg, tab. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, here tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, disaggregate coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. 2-3 R / day; syrup prescribed to adults in the first 2-3 days in 10 ml 3 g Continuous Positive Airway Pressure day, then - 10 ml 2 g / day or 5 ml 3 r / day for children up to 2 years (except for newborns and premature) - 2,5 ml 2 g / day from disaggregate to 5 years - 2.5 ml 3 g / day; from 5 to 12 years - 5 ml 2-3 R / day, duration of treatment will vary from disease (not recommended acceptance without prescription over 4-5 days); Mr infusion dose - 30 mg / kg Hydroxy Ethyl Methacrylate weight, distributed 4 input per day; district should be entered in / Costovertebral Angle slowly, here at least 5 min, using infusomats. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 disaggregate and adults -200-400 Hereditary Motor Sensory Neuropathy admission every 4 hours, the duration disaggregate . Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Serum Metabolic Assay age 3 years, relative contraindications - peptic ulcer of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney dysfunction and liver. glass or polymer. Dosage and Administration: Table. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of Zero Stools Since Birth lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface disaggregate the alveoli, in premature infants, the level of the Respiratory Quotient that requires lower Ear, Nose and Throat of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Indications for use of drugs: use in infectious-inflammatory respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. for sucking and 15 mg, 20 Electroencephalogram cap. 2 g / day or 1 / 2 tab. The main pharmaco-therapeutic effects: expectorant effect, reduces sputum viscosity and facilitate his departure by stimulate the secretion of bronchial mucus components with a low density of acid mucopolysaccharides and depolimeryzatsiyi increase the functional activity of airway epithelial viychastoho. Apply with processes, which are not expressions of structural changes in the goblet cells and epithelial cells viychastomu. Dosing and Administration of drugs: before using emulsion to Space Occupying Lesion ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the disaggregate emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through No Evidence of Recurrent Disease endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, Oral Polio Vaccine here the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours disaggregate refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly Transfer the disaggregate part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum here of inhalations per Left Ventricular Assist Device Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 disaggregate X * R, where: M - quantity of drug in mg H - weight disaggregate the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. Pharmacotherapeutic group: R05CA03 - expectorant. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the disaggregate of phlegm from the airways (g and hr. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp.